Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy - Yamamoto, Koichiro; Hokimoto, Seiji; Chitose, Tadasuke; Morita, Kazunori; Ono, Takamichi; Kaikita, Koichi; Tsujita, Kenichi; Abe, Tomohide; Deguchi, Mariko; Miyagawa, Haruna; Saruwatari, Junji; Sumida, Hitoshi; et al. (Journal of cardiology, 2011)
Keywords: Aged; Alleles; Aryl Hydrocarbon Hydroxylases - genetics; Asian Continental Ancestry Group; Cardiovascular; Cardiovascular Diseases - genetics; Coronary Disease - blood; Coronary Disease - drug therapy; Coronary heart disease; Cytochrome P-450 CYP2C19; Endovascular Procedures; Female; Genetics; Genotype; Humans; Male; Middle Aged; Pharmacology; Platelet Aggregation; Platelet Aggregation Inhibitors - administration & dosage; Platelets; Polymorphism, Genetic; Stents; Ticlopidine - administration & dosage; Ticlopidine - analogs & derivatives; Genetics; Pharmacology; Platelets; Coronary heart disease